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Overweight and obesity has been associated with a wide range of health and psychosocial 
problems that impact negatively on quality and length of life. The exact relationship between 
obesity and premature mortality is controvertible but there are strong and clear associations 
between increasing weight and risk of most major chronic diseases. Obesity is now the 
most common chronic disorder of childhood, and may adversely affect a child’s health with 
immediate medical and psychosocial consequences. However the more significant risk in 
children and adolescents who are obese is the tendency for obesity to persist in adulthood 
leading to greater potential for the early development of chronic disease and reduced life 
expectancy.
The validity of adverse health implications in relation to excessive body fat in childhood 
and adolescence has come into question in recent years, with warnings that exaggeration 
of risk may lead to potential increases in eating disorders or body image problems [1, 2]. 
However, a substantial body of research exists demonstrating that both overweight and 
obesity can have profound effects on the health of a child or adolescent [3, 4]. 
Childhood obesity is a multisystem disease with significant immediate and long-term 
medical and psychosocial complications, which were previously associated with onset in 
adulthood. Ethnic origin, cultural background, genetic susceptibility, environmental factors 
and socioeconomic status contribute to the risk of developing obesity-related complications. 
Furthermore, childhood overweight and obesity tracks into adolescence and adulthood. A 
recent systematic review found that persistence of overweight and obesity was greater with 
increasing weight status and age [5]. For overweight children (under 12 years of age), the 
risk of becoming an overweight adult ranged from two- to tenfold compared with normal 
weight children. For obese children the relative risk for becoming an obese adult was in 
the higher range. Similarly, for overweight/obese adolescents (aged 12 to 18 years), the 
risks of becoming overweight/obese as an adult was higher than in younger children, with 
between 24%–90% of overweight adolescents becoming overweight/obese adults. Risk of 
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persistence of obesity is also greater if at least one parent of the child or adolescent is obese 
[6]. Obesity early on in life is a predictor of later morbidity and mortality [6]. Given that 
obesity during adolescence increases the risk for chronic disease and premature death in 
adulthood, independently of adult obesity, forecasts of potential decline in life expectancy 
of current and future generations are perturbing and plausible [7, 8].
The following gives an overview of clinically important medical and psychosocial 
complications associated with childhood and adolescent overweight and obesity. Table 1 
provides a summary of these complications.
Table 1. Potential obesity-associated complications among children and adolescents
System Health problems
Psychosocial Social isolation and discrimination, decreased self-esteem, learning 
difficulties, body image disorder, bulimia
Medium and long term: poorer social and economic ‘success’, bulimia
Respiratory Obstructive sleep apnoea, asthma, poor exercise tolerance
Orthopaedic Back pain, slipped femoral capital epiphyses, tibia vara, ankle sprains, flat 
feet
Hepatobiliary Non-alcoholic fatty liver disease, gallstones, gastro-oesophageal reflux
Reproductive Polycystic ovary syndrome, menstrual abnormalities
Cardiovascular Hypertension, adverse lipid profile (low HDL cholesterol, high triglycerides, 
high LDL cholesterol), raised inflammatory markers
Medium and long term: increased risk of hypertension and adverse lipid 
profile in adulthood, increased risk of coronary artery disease in adulthood, 
left ventricular hypertrophy
Endocrine Hyperinsulinaemia, insulin resistance, impaired glucose tolerance, impaired 
fasting glucose, type 2 diabetes mellitus
Medium and long term: increased risk of type 2 diabetes mellitus and 
metabolic syndrome in adulthood
Neurological Benign intracranial hypertension
Skin Acanthosis nigricans, striae, intertrigo
Psychosocial impact
The most prevalent of obesity-related complications are related to psychosocial 
consequences, with risk being greater in girls compared to boys, and increasing with age 
[6]. Childhood obesity is highly stigmatised, with affected children being seen by other 
children as young as four years, as lazy, unhygienic and socially incompetent [9]. Peer-
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relationship problems are more prevalent in overweight and obese children, adolescents 
and even preschool-aged children [10]. Low self-esteem, anxiety and depression, and 
social isolation are more common in overweight and obese children and adolescents who 
may also suffer high levels of teasing and bullying [9]. Weight-based teasing may further 
contribute to negative psychosocial behaviour, including disordered eating, depression and 
suicidal ideation [11]. Overweight school-aged children are more likely to be bullied than 
normal-weight peers with obese children even more so [12, 13]. Bullying may take the form 
of physical aggression (overt bully) or what is termed relational bullying (eg withdrawing 
friendship or spreading lies). Bullying reportedly reduces throughout adolescence but 
whether this also occurs in relation to overweight/obesity is undetermined, though Janssen 
and colleagues report an association between weight status and peer victimisation in 11 to 
14 year olds but not in 15 to 16 year olds [13]. Differentiation in relation to bullying, gender 
and weight is also unclear. There is a suggestion however that overweight/obese boys tend 
to suffer overt bullying whereas overweight/obese girls are victims of relational bullying 
[14]. Furthermore, presumably because of increased size in relation to peers thus enabling 
physical dominance, obese boys are more likely to be overt bullies [12].
Overweight and obese children tend to have reduced athletic ability, potentially leading to 
exclusion from physical activities and contributing to a vicious cycle of reduced opportunity 
to improve gross motor skills, further exclusion and inactivity [15]. Similarly, weight status 
may have a negative influence on academic achievement. Poorer school performance 
may result from a combination of factors. An increase in absenteeism has been noted in 
overweight and obese children compared with normal-weight peers, and reduced school 
attendance is associated with negative academic outcomes [16]. Absenteeism may be as a 
result of obesity-related ill-health or from school avoidance, which may be secondary to 
victimisation. Furthermore, difficulties with concentration secondary to sleep deprivation 
from obstructive sleep apnoea (see below) may also contribute to poor academic 
performance.
Many obese children have good self-esteem with few or no psychological issues. However, 
a systematic review of cross-sectional, longitudinal and intervention studies found strong 
evidence of a negative impact on global self-esteem and quality of life in obese children and 
adolescents compared with healthy-weight peers, with no clear differences in age groups 
[17]. Moreover, in the severely obese treatment-seeking child, the psychosocial impact of 
obesity can be profound, with studies indicating a significant reduction in health-related 
quality of life, with impairment equating to that of a child diagnosed with cancer [15, 17]. 
In addition, the psychosocial problems may persist into adulthood, particularly for obese 
adolescent girls. Longitudinal data indicate young obese women are less likely to marry, 
have fewer years of higher education, and have higher rates of poverty with lower levels of 
income compared with normal weight peers [18]. 
Obstructive sleep aponea (OSA) 
Obesity is a major risk factor for sleep-disordered breathing, particularly obstructive sleep 
apnoea (OSA), a condition characterised by recurrent prolonged episodes of partial and/
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or complete upper-airway obstruction resulting in disruption of normal breathing and 
sleep patterns. The prevalence of OSA in the normal paediatric population is around 2%; 
however in children and adolescents with obesity the prevalence is significantly higher, 
ranging from 13% to 59%, depending on diagnostic criteria, age, ethnicity and pubertal 
status [19, 20]. For every 1 kg/m2 increment in body mass index beyond the mean for age 
and sex, the risk of OSA appears to increase by 12% [21]. The underlying mechanisms for 
this increased risk are unknown. It is not simply related to enlargement (hypertrophy) of 
the tonsils, as, even after adeno-tonsillectomy (first line treatment in OSA in children and 
adolescents), residual OSA persists in around 50% of obese children compared with only 
10%–20% of non-obese children [22].
Untreated OSA is associated with attention and behavioural problems (found in up to 
58% of obese children, compared with 10% of the general paediatric population [23]), 
cognitive impairment and poor school performance, in part as a result of disturbed sleep 
and even recurrent low level hypoxia. Furthermore, OSA has been associated with cardio-
metabolic complications, such as hypertension, ventricular hypertrophy, insulin resistance 
and abnormal blood lipid profile. The common pathway appears to be induction of 
chronic inflammation, the process beginning in childhood and persisting into adulthood, 
particularly if the OSA is left untreated [24].
Insulin resistance and type 2 diabetes mellitus 
Childhood obesity is associated with a number of metabolic complications, including 
insulin resistance (IR), a pre-diabetic state. The presence of insulin resistance increases the 
risk of developing type 2 diabetes mellitus and cardiovascular disease, and also appears to 
predict future cardiovascular risk [25]. The prevalence of insulin resistance is difficult to 
ascertain as there is no single simple reliable marker to determine a universal cut-point. 
Furthermore ethnicity and age (in particular pubertal status) influence insulin levels. 
However, studies using a simple blood marker of insulin resistance (homeostasis model of 
insulin resistance) have found a prevalence of IR ranging from 45%–80% in obese children, 
10%–60% in overweight children and 2%–20% in normal-weight children [26]. Similarly, 
in the 2004 New South Wales Schools Physical Activity and Nutrition Study, in which 
fasting blood from randomly sampled 15-year-old school students was analysed, raised 
levels of fasting insulin (another marker of insulin resistance) were found in 68%, 30% 
and 7%, of obese, overweight and healthy-weight boys respectively, and in 44%, 42% and 
11% of obese, overweight and healthy-weight girls respectively [27]. Increasing body mass 
index and deep abdominal fat are associated with increasing insulin resistance and there is 
a degree of heritability with an increased risk of developing insulin resistance in those with 
a strong family history of type 2 diabetes.
The number of cases of type 2 diabetes has been increasing in the paediatric population 
over the past couple of decades in parallel with the rise in paediatric obesity. The overall 
prevalence of children and adolescents with type 2 diabetes is 1%–4%, with rates being 
much higher in certain racial and ethnic groups, including Native American, African 
American, Hispanic, Indian sub-continent and Indigenous Australian populations, and 
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lower in northern European countries [28]. Type 2 diabetes in childhood can present 
with life-threatening ketoacidosis (around 10% of cases) or hyperglycaemic hyperosmolar 
non-ketotic syndrome (3.7% of cases) [29, 30]. The consequences of type 2 diabetes in 
young people may be more marked than in adults. Disease progression is normally related 
to decline in beta-cell function and altered insulin sensitivity. The decline in glycaemic 
control following initial diagnosis of type 2 diabetes tends to occur over a period of ten 
to 12 years in adults, but appears to evolve more rapidly in children, within two to four 
years of diagnosis, with those presenting in diabetic ketoacidosis manifesting greater and 
more rapid decline [31]. In addition, cardiovascular fitness is significantly impaired in 
comparison with obese youth who do not have type 2 diabetes.
Hypertension, cardiovascular disease and the metabolic syndrome
Obesity in childhood, and especially adolescence, is associated with the development of 
cardiovascular abnormalities, including atherosclerotic changes in the aorta and cardiac 
vasculature, and decreased arterial distensibility. Furthermore, obese children are more 
likely to develop such changes at an earlier age than normal-weight children [32, 33]. Both 
left ventricular hypertrophy and arterial hypertension are significantly more prevalent 
in obese children and adolescents, with the prevalence of hypertension increasing 
progressively with body mass index. Adolescents with obesity are three times more likely 
to be hypertensive than those in lower weight ranges [34, 35]. Arterial hypertension is a 
highly prevalent cardiovascular risk factor in young obese individuals and is predictive of 
sustained hypertension and end-organ damage in early adulthood [36]. In the previously 
mentioned 2004 NSW Schools Physical Activity and Nutrition Survey, high blood pressure 
was found in 37%, 36% and 14% of obese, overweight and healthy-weight boys, respectively, 
and in 22%, 7% and 5% of obese, overweight and healthly-weight girls, respectively [27].
The clustering of cardiovascular risk factors (insulin resistance, hypertension, abdominal 
obesity and dyslipidaemia – also termed the metabolic syndrome) are predictors of adult 
cardiovascular disease. Clustering of two or more cardiovascular risk factors is more 
prevalent in obese children and adolescents, and, depending on the definition used, 
1.2%– 22.6% of children and adolescents have the metabolic syndrome, with rates ranging 
from 30% up to 60% observed in those who are overweight or obese [36–38]. Moreover, 
mid-childhood obesity is associated with a sevenfold increased chance of developing 
cardiovascular disease risk factors in adolescence [39].
Dyslipidaemia 
Dyslipidaemia, most commonly raised serum concentrations of low-density lipoprotein 
(LDL) cholesterol and triglycerides and reduced concentrations of high-density lipoprotein 
(HDL) cholesterol, occurs in overweight and obese children and adolescents, particularly 
those who have abdominal obesity. Up to 50 % of obese adolescents may have some degree 
of dyslipidaemia [40, 41].
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Fatty liver disease
Paediatric obesity is associated with a spectrum of liver abnormalities known as non-
alcoholic fatty liver disease (NAFLD).The disease ranges from simple fatty infiltration of 
the liver (hepatic steatosis), to fatty liver with inflammation and fibrosis (non-alcoholic 
steatohepatitis). NAFLD is the most common paediatric liver abnormality, related to the 
increasing childhood obesity epidemic and is associated with the metabolic syndrome 
(central obesity, hypertension, dyslipidemia and insulin resistance). The true prevalence 
and severity of NAFLD is unknown because of problems with standardisation of disease 
definition, diagnostic modalities and variations by ethnicity. However, prevalence ranges 
from 3%–77% in obese children and adolescents have been quoted [42]. Additionally, the 
natural history of paediatric NAFLD is not established as long-term studies are lacking. 
Current evidence suggests that a minority of adolescents with NAFLD develop progressive 
liver disease, leading to liver failure or transplantation, and this is most likely in patients 
with advanced fibrosis at baseline [43]. 
Musculoskeletal complications
There is increased awareness that child and adolescent obesity may not only lead to major 
orthopaedic complications, such as slipped capital femoral epiphyses (where the developing 
head of the femur shifts backwards resulting in a weakened hip joint) and tibia vara (Blount 
disease, progressive bowing of the legs), but also a number of other issues involving the 
whole of the musculoskeletal system. Compared with normal-weight peers, obese children 
and adolescents have a higher incidence of musculoskeletal pain (eg back pain, lower limb 
pain especially knees and feet), and genu valgum (knocked knees), greater hinderance to 
lower limb functioning and gait, and increased risk of fractures (as obese children generally 
have reduced bone mass after adjusting for size and often vitamin D deficiency as well) 
[44]. Slipped capital femoral epiphyses, a debilitating condition of the hip joint requiring 
surgical intervention, is significantly associated with obesity: up to 80% of cases of slipped 
capital femoral epiphyses are associated with obesity. Unfortunately, weight loss does not 
resolve the condition, although it helps alleviate the severity and potential for developing 
bilateral disease. Likewise Blounts disease is strongly associated with increased weight 
whereby weight loss alleviates but does not resolve the condition [44].
Polycystic ovary syndrome
Obese adolescent girls are at risk of polycystic ovary syndrome (PCOS), a syndrome 
of elevated androgen levels and ovulatory dysfunction. The prevalence appears to be 
increasing. It is associated with obesity, insulin resistance, and other elements of the 
metabolic syndrome. It should be suspected in girls, with hirsutism or severe acne and/or 
menstrual irregularity, especially if they have obesity and insulin resistance [45]. There is 
mounting evidence that females with PCOS are at increased long-term risk of endometrial 
cancer (if PCOS is untreated), cardiovascular and metabolic complications later in 
adulthood. PCOS is also the most common cause for infertility. 
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Idiopathic intracranial hypertension
Idiopathic intracranial hypertension (also known as pseudotumour cerebri), is more 
prevalent in obese children and adolescents, although more so in obese adolescents rather 
than younger children [46]. It is a rare condition which can cause severe visual impairment 
or blindness and presents with headaches and a range of potential symptoms. 
Skin problems
Obesity is associated with a number of skin manifestations, including acanthosis nigricans, 
in association with insulin resistance. Acanthosis nigricans appears as hyperpigmented, 
velvety-thickened skin most often seen on the neck, in the axillae, groin, knuckles or knees. 
It may be mistaken for a dirty neck and may be a cause of embarrassment in more marked 
cases. Treatment of the insulin resistance, either by weight loss or pharmacologically, results 
in reduction or resolution of the manifestation. Other skin complications associated with 
obesity include striae (stretch marks) and a tendency for fungal infections (intertrigo) in 
areas where moisture is trapped, such as in skin folds. 
Other medical complications
The above list of obesity-associated complications is not exhaustive. Additional 
complications such as gastro-oesophageal reflux disease, constipation, daytime wetting 
and nocturnal enuresis (bedwetting), nutritional deficiencies, gallstone formation and 
bulimia are all problems that are either exacerbated by the association of obesity or have 
an increased prevalence in overweight and obese children and adolescents. Moreover, 
seemingly less major difficulties, such as an inability to attend to personal hygiene or reach 
to tie one’s shoelaces, can result from being obese and have a major impact on quality of 
life. 
Conclusion
Childhood and adolescent obesity is a multifactorial, multisystem disease, the prevalence 
of which has been rising exponentially in recent decades. A considerable body of evidence 
exists highlighting the significant adverse health-related impacts of childhood and 
adolescent obesity. Recognised obesity-related complications range from psychosocial 
issues, these being the most prevalent, to medical ailments such as insulin resistance, 
hypertension and non-alcoholic fatty liver disease. Importantly, the adverse effects may not 
only have immediate implications but also can affect health in the longer term, independent 
of adult obesity. As childhood obesity tends to persist into adulthood, the risk of obesity-
related morbidity and mortality is further increased. However, a reduction in total body 
fat has the potential to alleviate or resolve the adverse health outcomes, thus appropriate 
assessment and management of such children and adolescents is warranted. 
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